Christian Walker

Christian Walker Email and Phone Number

CEO and Founder @ Solaxa Inc.
Bethesda, MD, US
Christian Walker's Location
Bethesda, Maryland, United States, United States
Christian Walker's Contact Details

Christian Walker work email

Christian Walker personal email

About Christian Walker

Innovative, senior-management executive with 20 plus years of experience in life sciences and regenerative medicine start-ups to publicly traded companies. Creative, self-driven, multi-faceted professional, able to articulate and implement vision from business plan to obtaining funding to successful implementation and exit. Proven track record of raising money and non-dilutive financing, including grant writing, angel investments, venture capital and IPO. Talent management and scientific expertise from bench and translational studies to FDA regulated human phase I/II/II clinical trials of stem cells and HIPAA compliant devices. Real-world experience taking products from development through regulatory approval to successful market launch and revenue generation.

Christian Walker's Current Company Details
Solaxa Inc.

Solaxa Inc.

View
CEO and Founder
Bethesda, MD, US
Website:
solaxa.com
Employees:
10
Christian Walker Work Experience Details
  • Solaxa Inc.
    Ceo And Founder
    Solaxa Inc.
    Bethesda, Md, Us
  • Solaxa Inc.
    Ceo & Founder
    Solaxa Inc. Nov 2019 - Present
    Bethesda, Maryland, Us
    Solaxa is repurposing FDA approved drugs and biologics to improve the early and accurate identification and treatment of recoverable nerve injury. Responsible for ideation, licensing, authoring grants, establishing strategic partners, recruiting team, and forming company and leading fundraising efforts. Established first product development effort leading to ongoing feasibility study.
  • Neuraptive Therapeutics
    Business & Translational Development
    Neuraptive Therapeutics Oct 2019 - Jun 2022
    Chesterbrook, Pa, Us
    Create and implement business strategies to support commercialization of Neuraptive’s lead product NTX-001, which uses PEG-fusion to transform peripheral nerve repair. Responsible for translating promising peripheral nerve technologies into marketable products ready for clinical trial.
  • Axogen, Inc.
    Regenerative Medicine Commercialization
    Axogen, Inc. Apr 2018 - Sep 2019
    Alachua, Fl, Us
    Returned to AxoGen after managing and achieving primary endpoint for first in-human peripheral nerve-scaffold and autologous stem cell Phase I clinical trial at Walter Reed. Conducted in depth competitive threat analysis and future product roadmaps including IP strategy and business development efforts.
  • The Henry M. Jackson Foundation For The Advancement Of Military Medicine
    Director, Peripheral Nerve Institute
    The Henry M. Jackson Foundation For The Advancement Of Military Medicine Aug 2015 - Apr 2018
    Bethesda, Md, Us
    Responsible for design, implementation and execution of regenerative medicine human clinical trials consisting of medical devices, biologics, and combination products according to GCP, ICH and CFR principles at Walter Reed. Directed both translational and basic research at Uniformed Services University. Oversaw $7.5M in DoD funded research and managed staff of 10. Clinical focus was on traumatic injuries using innovative regenerative medicine products for nerve, skin and muscle repair. Laboratory and animal studies focused on heterotopic ossification and novel methods to induce pluripotency based upon observation of stem cell expansion in excised tissue from wounded service members.
  • Axogen, Inc.
    Business Development
    Axogen, Inc. Jun 2012 - Aug 2015
    Alachua, Fl, Us
    Re-started new product development efforts, leading to two new commercial product launches. Authored multiple DoD grants which were awarded over $4.5M in funding in partnership with Brigham & Women’s Hospital and Walter Reed. Negotiated and executed intellectual property licenses with technology transfer offices at top academic institutions.
  • Journal Of Commercial Biotechnology
    Associate Editor
    Journal Of Commercial Biotechnology Mar 2012 - Aug 2015
    The Journal of Commercial Biotechnology, in print since 1994, is the definitive international quarterly publication for bioscience business professionals. The Journal is designed specifically for those professionals who need to enhance their knowledge of biotechnology business strategy and management, improve and advance their product development or want to keep up-to-date with current issues and industry trends.
  • Johns Hopkins Medicine
    Director, Military & Veterans Health Institute
    Johns Hopkins Medicine Aug 2011 - Jun 2012
    Baltimore, Md, Us
    Launched new military-focused institute at Johns Hopkins to build support, develop infrastructure for groundwork and bring start-up mentality to MVHI. Supported business development and authored military funding requests leading to over $15M in funded awards including AFIRM II. Focused on cross-enterprise collaboration to leverage Johns Hopkins expertise into military-focused healthcare solutions. Successful application to Invest Maryland VC Fund.
  • Tunnell Government Services
    Principal, Regenerative Medicine Commercialization
    Tunnell Government Services Oct 2010 - Jul 2011
    Bethesda, Md, Us
    Served as a Portfolio Manager to the Armed Forces Institute of Regenerative Medicine (AFIRM) and Clinical and Rehabilitative Medicine Research Program at Fort Detrick. Provided strategic guidance for and managed the commercialization of approximately $200 million dollars in active R&D and clinical expenditures for programs throughout the DoD, including CDMRP and TATRC. Focus was on down-selection of products that lacked solid commercialization pathway and multi-tiered support for those that did, leading to multiple product launches.
  • Telcare Inc.
    Evp Of Operations
    Telcare Inc. Mar 2009 - Jun 2010
    Malvern, Pennsylvania, Us
    As first employee, helped launched medical device start-up, leading to sale of first FDA cleared cellular-embedded wireless glucose meter to increase testing compliance. When paired with HIPAA compliant patient and caregiver messaging, statistically significant reductions in HbA1c occurred. Coordinated and managed all business operations, developed and implemented successful intellectual property and regulatory strategies. Authored and implemented ISO:9001 Quality System. Telcare was acquired in 2016 by BioTel Care which was subsequently acquired by Phillips.
  • Toucan Capital
    Principal
    Toucan Capital Jun 2007 - Jul 2009
    Bethesda, Maryland, Us
    Served as Principal of $140 million venture capital fund focused on early-stage investments in stem cells and regenerative medicine. Managed Toucan’s investments in MedRelief Inc. and CELTHERA. Analyzed and managed Toucan’s composition of matter stem cell portfolio of over 400 patents and created novel commercialization strategies. Served on Maryland Incubator Company of the Year Award Committee. Authored components of AFIRM I commercialization plan and participated in winning $75M proposal submission in collaboration with Wake Forest University.
  • Medrelief Inc.
    Ceo
    Medrelief Inc. Jan 2008 - Apr 2009
    Appointed by Toucan Capital to turn around medical device start-up in portfolio. Company featured an unfocused, multi-product, multi-market approach; succeeded in refocusing business strategy on osteogenesis and stem cell differentiation using electric fields for osteoporosis. Restructured company, established new corporate entity and closed $6.5M in debt and equity financing. Responsible for multi-site domestic & international double-blind clinical trials, achieving statistically significant outcomes resulting in increased bone density.
  • Harvard Medical School
    Outreach Manager
    Harvard Medical School Mar 2003 - Mar 2004
    Boston, Ma, Us
    Liaised with public and local community to promote the mission and goals of the Immune Defense Institute, a globally recognized non-profit research institute focused on the treatment and management of immune disease. Raised funds to provide training and cutting-edge scientific laboratory equipment to support Boston Public School outreach programs. Designed innovative, award-winning, curriculum that was the adopted by participating instructors for classroom implementation. Directed internship program to train students for successful placements in Harvard Medical School laboratories.
  • Evacyte
    Ceo & Founder
    Evacyte Jan 2000 - Feb 2002
    Raised $2M in seed, debt & Series A financing for an award-winning oncology-focused start-up company. Developed and executed a successful business plan and recruited senior management and staff. Licensed exclusive rights to patented research from the University of Texas at Austin. Negotiated and led sponsored research program to continue development and collaboration of the breakthrough Optical Stretcher technology, used to highly effective detect a progression of metastatic cancer. Managed and guided transformation from academic research to marketable product in 18 months. Evacyte ceased operation post 9/11.
  • New Mission High School
    Teacher, Founder
    New Mission High School 1995 - 1999
    As a Boston Latin student teacher, authored and secured $3.5M of funding from the City of Boston to open a new pilot high school, targeting disadvantaged students. New Missions High School’s objective is to empower students to become self-directed, life-long learners within a creative, challenging, and rigorous learning environment. The school is in its 27th year of operation. New Mission High has achieved a 98% graduation rate tied with Boston Latin compared to a 72% graduation rate for other Boston public schools.

Christian Walker Skills

Regenerative Medicine Biotechnology Technology Commercialization Venture Capital Entrepreneur Life Sciences Stem Cells Cell Therapy Biomedical Engineering Medical Devices Entrepreneurship Start Ups Lifesciences Strategy Commercialization Clinical Trials Program Management Cell Biology Business Development Healthcare Business Strategy Technology Transfer Immunology Molecular Biology Clinical Research Cancer Cell Culture Genomics Leadership

Christian Walker Education Details

  • Umass Chan Medical School
    Umass Chan Medical School
    Biomedical Engineering & Biotechnology
  • Isenberg School Of Management, Umass Amherst
    Isenberg School Of Management, Umass Amherst
    Entrepreneurship
  • The University Of Texas At Austin
    The University Of Texas At Austin
    Cell And Molecular Biology
  • Umass Boston
    Umass Boston
    Science Education
  • University Of California, Santa Cruz
    University Of California, Santa Cruz
    Biology

Frequently Asked Questions about Christian Walker

What company does Christian Walker work for?

Christian Walker works for Solaxa Inc.

What is Christian Walker's role at the current company?

Christian Walker's current role is CEO and Founder.

What is Christian Walker's email address?

Christian Walker's email address is bi****@****ail.com

What schools did Christian Walker attend?

Christian Walker attended Umass Chan Medical School, Isenberg School Of Management, Umass Amherst, The University Of Texas At Austin, Umass Boston, University Of California, Santa Cruz.

What skills is Christian Walker known for?

Christian Walker has skills like Regenerative Medicine, Biotechnology, Technology Commercialization, Venture Capital, Entrepreneur, Life Sciences, Stem Cells, Cell Therapy, Biomedical Engineering, Medical Devices, Entrepreneurship, Start Ups.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.